Hims & Hers and Novo Nordisk are partners again, just weeks after Novo sued the telehealth giant for selling compounded GLP-1s.
Hims co-founder Hilary Coles and former marketing head Emily Boschwitz have launched Poca, a fiber-filled, zero-calorie syrup sweetener.
Hims & Hers is planting its flag in new overseas markets; on U.S. soil, it's navigating a GLP-1s fight against Big Pharma's branded blockbusters.
Amazon just became the next major player to enter the biomarker blood testing wars with the launch of Health Insights.
This year's Super Bowl LX ad slate shows just how much has changed in the conversation around health and wellness.
Hims & Hers returns to the Super Bowl with a pointed ad that takes aim at the health-wealth gap in the United States.
ATN breaks down Function Health's huge funding round and Hims & Hers' entry into blood testing, as well as the rise of in-person wellness events.
Hims & Hers has launched Labs, a subscription diagnostic service offering blood testing as consumers face rising healthcare costs.
Telehealth giant Hims & Hers has expanded into women's midlife care with personalized treatment plans, including patches, creams and pills.
New internal data suggests that Hims & Hers tailored weight loss model is improving outcomes and helping patients stick with their treatment.
Sign Up to Our Newsletter
